Menu Search
ETFs

Horizon Kinetics Medical ETF

MEDX:NMQ:USD

Horizon Kinetics Medical ETF

Actions
  • Price (USD)29.56
  • Today's Change0.34 / 1.16%
  • Shares traded10.85k
  • 1 Year change+3.47%
Data delayed at least 15 minutes, as of Nov 08 2024 21:15 GMT.
More ▼
Find Funds and ETFs
Find Funds and ETFs
Use our fund screener to discover other asset types.
 
Funds ScreenerGo to the Funds Screener

Asset allocation

Distribution

Type% Net assets% Short% Long
US stock74.51%0.00%74.51%
Non-US stock19.56%0.00%19.56%
Cash5.93%0.00%5.93%
US bond0.00%0.00%0.00%
Non-US bond0.00%0.00%0.00%
Other0.00%0.00%0.00%
As of Oct 31 2024

Weightings

Sectors
Equity
Fixed income
Sector% Net assetsCategory average
Healthcare94.07%97.70%
Other0.00%2.14%
Real Estate0.00%0.09%
Industrials0.00%0.04%
Consumer Defensive0.00%0.03%
As of Oct 31 2024. Sectors weighting is calculated using only long position holdings of the portfolio.

Top 10 holdings

Top 10 holdings as a per cent of portfolio
45.90%65.25%0.00%65.25%
Category average% Net assets% Short% Long
Company1 year changePortfolio weightLong allocation
Eli Lilly and Co
LLY:NYQ		+34.31%16.03%
AbbVie Inc
ABBV:NYQ		+40.46%9.00%
Amgen Inc
AMGN:NSQ		+19.04%6.18%
Novartis AG
0K9E:LSE		+12.60%5.98%
Bristol-Myers Squibb Co
BMY:NYQ		+3.28%5.69%
AstraZeneca PLC
0A4J:LSE		+2.17%5.10%
Johnson & Johnson
JNJ:NYQ		+3.41%4.69%
Alnylam Pharmaceuticals Inc
ALNY:NSQ		+63.77%4.41%
Pfizer Inc
PFE:NYQ		-13.30%4.22%
Merck & Co Inc
MRK:NYQ		-1.42%3.95%
Per cent of portfolio in top 10 holdings: 65.25%
Data delayed at least 15 minutes, as of Nov 09 2024.
Data Provided by LSEG
The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.
All managed funds data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2024
All Rights reserved
www.morningstar.com
© 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.